NO179196C - Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on - Google Patents

Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on

Info

Publication number
NO179196C
NO179196C NO894281A NO894281A NO179196C NO 179196 C NO179196 C NO 179196C NO 894281 A NO894281 A NO 894281A NO 894281 A NO894281 A NO 894281A NO 179196 C NO179196 C NO 179196C
Authority
NO
Norway
Prior art keywords
benzisoselenazol
phenyl
preparation
parenteral solutions
stable parenteral
Prior art date
Application number
NO894281A
Other languages
English (en)
Norwegian (no)
Other versions
NO894281L (no
NO179196B (no
NO894281D0 (no
Inventor
Jorg Hager
Andrea Michaela Huther
Joachim Roding
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of NO894281D0 publication Critical patent/NO894281D0/no
Publication of NO894281L publication Critical patent/NO894281L/no
Publication of NO179196B publication Critical patent/NO179196B/no
Publication of NO179196C publication Critical patent/NO179196C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
NO894281A 1988-10-29 1989-10-26 Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on NO179196C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3836892A DE3836892A1 (de) 1988-10-29 1988-10-29 Parenteral applizierbare, stabile arzneimittelloesungen

Publications (4)

Publication Number Publication Date
NO894281D0 NO894281D0 (no) 1989-10-26
NO894281L NO894281L (no) 1990-04-30
NO179196B NO179196B (no) 1996-05-20
NO179196C true NO179196C (no) 1996-08-28

Family

ID=6366157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894281A NO179196C (no) 1988-10-29 1989-10-26 Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on

Country Status (12)

Country Link
EP (1) EP0366990B1 (pt)
JP (1) JPH0832629B2 (pt)
AT (1) ATE82848T1 (pt)
CA (1) CA2001325C (pt)
DE (2) DE3836892A1 (pt)
DK (1) DK173610B1 (pt)
ES (1) ES2052859T3 (pt)
FI (1) FI94835C (pt)
GR (1) GR3006865T3 (pt)
IE (1) IE63152B1 (pt)
NO (1) NO179196C (pt)
PT (1) PT92142B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201527A1 (de) * 1992-01-21 1993-07-22 Knoll Ag Lecithinhaltige loesungen mit levemopamil
US5720973A (en) * 1993-02-18 1998-02-24 Knoll Aktiengesellschaft Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
FR2730930B1 (fr) 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
RU2003119140A (ru) * 2000-12-28 2004-12-27 Дайити Фармасьютикал Ко., Лтд. (JP) Эмульсионный препарат
PT1888033E (pt) * 2005-06-09 2014-05-15 Meda Ab Método e composição para tratamento de distúrbios inflamatórios
SI1919450T1 (sl) * 2005-09-01 2014-10-30 Meda Ab Liposomski sestavek, ki vsebuje antihistaminik in kortikosteroid, in njegova uporaba za izdelavo zdravila za zdravljenje rinitisa in sorodnih motenj
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3568775D1 (en) * 1984-06-22 1989-04-20 Nattermann A & Cie S-(carbamoyl-phenylselenyl) derivatives of glutathion and of amino mercaptocarboxylic acids, process for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
CA2001325C (en) 1999-12-21
NO894281L (no) 1990-04-30
EP0366990A3 (en) 1990-12-19
CA2001325A1 (en) 1990-04-29
JPH02250876A (ja) 1990-10-08
EP0366990A2 (en) 1990-05-09
GR3006865T3 (pt) 1993-06-30
PT92142B (pt) 1995-06-30
DE3836892A1 (de) 1990-05-03
PT92142A (pt) 1990-04-30
FI94835B (fi) 1995-07-31
NO179196B (no) 1996-05-20
NO894281D0 (no) 1989-10-26
DK537889D0 (da) 1989-10-27
DK537889A (da) 1990-04-30
JPH0832629B2 (ja) 1996-03-29
ATE82848T1 (de) 1992-12-15
DE68903736D1 (de) 1993-01-14
DK173610B1 (da) 2001-04-30
DE68903736T2 (de) 1993-04-08
IE63152B1 (en) 1995-03-22
ES2052859T3 (es) 1994-07-16
FI895112A0 (fi) 1989-10-27
FI94835C (fi) 1995-11-10
IE893492L (en) 1990-04-29
EP0366990B1 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
PT81839B (pt) Processo de preparacao de formulacoes com propulsores de aerosol a base de clorofluorocarbono contendo medicamento
DK549189A (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DK319481A (da) Fremgangsmaade til fremstilling af forbindelse indeholdende 2-phenyl-1,2-benzioselenazol-3(2h)-on
NO175133C (no) Fremgangsmåte for fremstilling av et legemiddelpreparat med findelte 2-fenyl-1,2-benzisoselenazol-3(2H)-on
ES2065906T3 (es) Produccion de proteinas en formas activas.
NO179196C (no) Fremgangsmåte for fremstilling av stabile, parenterale opplösninger av 2-fenyl-1,2-benzisoselenazol-3(H)-on
ATE82857T1 (de) Interleukin-2-zusammensetzungen.
DK0826370T3 (da) Lægemiddel indeholdende 2-phenyl-1, 2-benzisoselenazol-3(2H)-on til behandling af Alzheimers sygdom
ATE171621T1 (de) Verwendung von 2-phenyl-1,2-benzisoselenazol- 3(2h)-on
DE69106008D1 (de) Behandlung von Schlaf-Apnoea mit Azapironderivaten.
KR900009591A (ko) 피리딘-3-퍼옥시카르복실산 모노퍼술페이트
ES8404358A1 (es) Un procedimiento para obtener derivados de isoxazolopirimidina.
FI901459A0 (fi) In vitro-syntes av ingripande rna.
DK301288A (da) Stabile uracilpraeparater
Kingston Socialist feminism: Necessary but insufficient: Comment on" Feminism and family therapy: A possible meeting point," by J. Pilias and J. Anderton.
IT8748444A0 (it) L'impiego in terapeutica dell'uro chinasi insieme con la pro-urochinasi
IT8847797A0 (it) Derivati dell' 1.3 -diossalano e dell'1.3-diossano e loro impiegocome medicamenti
ATE141104T1 (de) Gentechnische herstellung von protein pp 15.